In a historic move, the Union government has slashed the Goods and Services Tax (GST) rates for 33 cancer drugs and rare medicines — from 12 to zero per cent. The decision taken by the GST Council, chaired by Finance Minister Nirmala Sitharaman, on Wednesday, rationalised the indirect tax structure, cutting the current four slabs down to two — scrapping the 12 per cent and 28 per cent rates, while retaining the 5 per cent and 18 per cent slabs. Read more
JSA News
- February 16, 2026
CERC gets go-ahead to frame norms on power market coupling
- February 16, 2026
Banks to drive domestic M&A as RBI eases financing norms
- February 13, 2026
GIFT IFSC captures 65% of ECBs in FY26 on lower taxes, lighter rules
- February 13, 2026






